Gülfem Yıldırım

Resveratrol attenuates moxifloxacin-induced oxidative damage in the liver, kidneys, brain, and serum of Wistar rats

Resveratrol co-administration attenuated several moxifloxacin-associated oxidative and apoptotic alterations, particularly in the kidney and liver tissues, but the absence of a resveratrol-only group and the preconditioning design limit the interpretation of its independent effects and clinical applicability.